16th International Congress of Mucosal Immunology (ICMI 2013)

第十六届国际粘膜免疫学大会(ICMI 2013)

基本信息

  • 批准号:
    8597660
  • 负责人:
  • 金额:
    $ 0.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-10 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Society for Mucosal Immunology's (SMI) biennial meeting, the 16th International Congress of Mucosal Immunology (ICMI) is widely recognized as the pre-eminent conference on mucosal immunology combining high-quality basic science with the clinical situation. Educational content focuses on the educational theme of the meeting, Pioneering Frontiers in Mucosal Regulation. Scientific sessions will promote excellence in research and education in the field of mucosal immunology and will foster future communication and scientific advancement among immunologists. This ICMI follows 15 successful biennial meetings, recently held in Paris is 2011, Boston in 2009 and Tokyo in 2007, wherein nearly 1,000 scientists in the broad fields of mucosal immunology assembled. ICMI 2013, co-chaired by Ken Croitoru, MDCM, Dana Philpott, PhD and Jo Viney, PhD will deliver another exciting scientific meeting. The meeting includes 35 keynote and plenary speakers who will present new information in areas relating to the molecular basis of microbial immune interactions at the mucosal surfaces, new insights into the understanding of mucosal diseases of humans, regulatory cells and their relationship to mucosal immunology, mechanisms of inflammation, the epithelial barrier in immunity, innate immunity, immunoglobulin and B-cell functions, mucosal vaccines and genetics. These sessions will be enhanced by an additional 30 invited speakers who will chair abstract-driven sessions on regulatory T-cells, the immunology of the epithelium, vaccines and mucosal infections, dendritic cells, cytokines, urogenital immunology, pulmonary immunology, inflammation, allergy, inflammatory bowel disease, celiac disease, lymphocyte homing, cytokines and chemokines, inflammation, mucosal antibodies, ocular and upper airway mucosal immunology, probiotics, innate immunity, antimicrobial defenses, among other topics. The educational content of ICMI 2013 was developed by SMI's International Planning Committee, which is comprised of leaders in the mucosal immunology field. As experts, committee members engage in discussions in which topics are identified and developed into sessions. Committee members draw from their extensive knowledge, and also consult evaluations and topic suggestions collected from previous congresses to create a program that addresses the most relevant and pressing topics in mucosal immunology. They also refer to data collected from membership surveys requesting topic suggestions and perceived gaps in knowledge. In addition to highlighting the best science, ICMI 2013 is an incubator for developing scientists and practitioners alike to meet with one another along with representatives of relevant biotechnology and pharmaceutical industry. The first three days include poster and oral abstract presentations to give young investigators the change to have their work presented and critiqued. SMI takes a specific interest in the development of young investigators and provides travel awards to them to supplement their costs to attend the meeting. In addition to encouraging the participation of new investigators, SMI recognizes the importance of participation from a wide range of demographics. Every effort is made to include a diverse representation within the ICMI International Planning Committee and the ICMI's Scientific Program. The success of the previous 15 ICMI meetings attests to this effort. Support is now requested to support ICMI 2013, which will continue this valuable effort.
描述(由申请人提供):粘液免疫学学会(SMI)两年一次的会议,第16届国际粘液免疫学大会(ICMI)被广泛认为是将高质量的基础科学与临床情况相结合的粘膜免疫学杰出会议。教育内容集中在会议的教育主题,开拓前沿的粘液调节。科学会议将促进粘膜免疫学领域的卓越研究和教育,并将促进免疫学家之间的未来交流和科学进步。本次ICMI是继2011年在巴黎、2009年在波士顿和2007年在东京成功举办的15次两年一次的会议之后召开的,在这些会议上,粘膜免疫学广泛领域的近1,000名科学家聚集在一起。ICMI 2013由MDCM的Ken Croitoru、Dana Philpott博士和Jo Viney博士共同主持,将举办另一场激动人心的科学会议。会议包括35个主旨和全体发言人,他们将在与粘膜表面微生物免疫相互作用的分子基础有关的领域提供新的信息,对人类粘膜疾病的理解的新见解,调节细胞及其与粘膜免疫学的关系,炎症机制,免疫中的上皮屏障,先天免疫,免疫球蛋白和B细胞功能,粘膜疫苗和遗传学。这些会议将由另外30名特邀演讲者加强,他们将主持关于调节性T细胞,上皮免疫学,疫苗和粘膜感染,树突状细胞,细胞因子,泌尿生殖免疫学,肺免疫学,炎症,过敏,炎症性肠病,乳糜泻,淋巴细胞归巢,细胞因子和趋化因子,炎症,粘膜抗体,眼和上呼吸道粘膜免疫学,益生菌,先天免疫,抗菌防御,以及其他主题。ICMI 2013的教育内容由SMI的国际规划委员会开发,该委员会由粘膜免疫学领域的领导者组成。作为专家,委员会成员参与讨论,确定主题并发展为会议。委员会成员利用他们广泛的知识,并咨询从以前的大会收集的评估和主题建议,以创建一个解决粘膜免疫学中最相关和最紧迫的主题的计划。它们还提到从成员调查中收集的数据,要求提出专题建议和认识到的知识差距。除了突出最好的科学,ICMI 2013是一个培养科学家和从业人员的孵化器,沿着相关生物技术和制药行业的代表。前三天包括海报和口头摘要介绍,让年轻的研究人员有自己的工作提出和批评的变化。SMI特别关注年轻调查员的发展,并向他们提供旅费,以补充他们参加会议的费用。除了鼓励新研究者的参与外,SMI还认识到广泛的人口统计学参与的重要性。尽一切努力在ICMI国际规划委员会和ICMI的科学方案中纳入各种代表。国际海事研究所前15次会议的成功证明了这一努力。现在请求提供支持,以支持将继续这一宝贵努力的2013年国际海事研究所会议。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOANNE L Viney其他文献

JOANNE L Viney的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 0.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了